Results 11 to 20 of about 209,877 (306)

β-diketonate versus β-ketoiminate:the importance of a ferrocenyl moiety on improving the anticancer potency [PDF]

open access: yes, 2020
Herein we present a library of fully characterized beta-diketonate and beta-ketoiminate compounds that are functionalized with a ferrocenyl moiety. Their cytotoxic potential has been determined by screening against human breast adenocarcinomas (MCF-7 and
Allison, Matthew   +4 more
core   +2 more sources

Tamoxifen induces ferroptosis in MCF-7 organoid

open access: yesJournal of Cancer Research and Therapeutics, 2023
Background: Breast cancer is the most common female malignant tumor type globally. The occurrence and development of breast cancer involve ferroptosis, which is closely related to its treatment. The development of breast cancer organoids facilitates the analysis of breast cancer molecular background and tumor biological ...
Lei, Ye   +6 more
openaire   +2 more sources

Coenzyme Q Depletion Reshapes MCF-7 Cells Metabolism [PDF]

open access: yesInternational Journal of Molecular Sciences, 2020
Mitochondrial dysfunction plays a significant role in the metabolic flexibility of cancer cells. This study aimed to investigate the metabolic alterations due to Coenzyme Q depletion in MCF-7 cells. Method: The Coenzyme Q depletion was induced by competitively inhibiting with 4-nitrobenzoate the coq2 enzyme, which catalyzes one of the final reactions ...
Wang W.   +6 more
openaire   +4 more sources

Potential Therapeutic Effect of Natural Killer Cells on Doxorubicin-Resistant Breast Cancer Cells In Vitro. [PDF]

open access: yesPLoS ONE, 2015
The aim of this study was to explore the therapeutic effect of natural killer (NK) cells on human doxorubicin-sensitive and resistant breast adenocarcinoma.Human doxorubicin-sensitive and resistant breast cancer cell lines (MCF-7 and MCF-7/ADR) were ...
Mi-Hye Hwang   +6 more
doaj   +1 more source

Downregulation of Choline Kinase-Alpha Enhances Autophagy in Tamoxifen-Resistant Breast Cancer Cells. [PDF]

open access: yesPLoS ONE, 2015
Choline kinase-α (Chk-α) and autophagy have gained much attention, as they relate to the drug-resistance of breast cancer. Here, we explored the potential connection between Chk-α and autophagy in the mechanisms driving to tamoxifen (TAM) resistance, in ...
Hoe Suk Kim   +6 more
doaj   +1 more source

Secondary metabolites, antioxidant, and antiproliferative activities of Dioscorea bulbifera Leaf Collected from Endau Rompin, Johor, Malaysia [PDF]

open access: yes, 2021
Breast cancer is among the most commonly diagnosed cancer and the leading cause of cancer-related death among women globally. Malaysia is a country that is rich in medicinal plant species. Hence, this research aims to explore the secondary metabolites,
Abu Bakar, Fazleen Izzany   +5 more
core   +1 more source

IGF-1 regulates Cyr61 induced breast cancer cell proliferation and invasion. [PDF]

open access: yes, 2014
BackgroundStudies from our laboratory and others have shown that cysteine-rich 61 (Cyr61) may be involved in tumor proliferation and invasion. In earlier studies, we demonstrated increased insulin-like growth factor-I (IGF-1) is associated with breast ...
Cardenas, Jessica   +5 more
core   +6 more sources

Gynura procumbens Prevents Chemoresistance through Inhibition MDR1 Expression on MCF-7 Breast Cancer Cell Line and Sensitizes the Cells to Doxorubicin

open access: yesIndonesian Journal of Biotechnology, 2012
The long-term exposure of doxorubicin (Dox) causes enhancement in MDR1 expression that leads to breast cancer cell resistance. This protein become a serious problem in cancer treatment and also well-known as negative prognostic factor in breast cancer ...
Nunuk Aries Nurulita   +3 more
doaj   +1 more source

Role of insulin-like growth factor binding protein-3 in 1, 25-dihydroxyvitamin-d 3 -induced breast cancer cell apoptosis. [PDF]

open access: yes, 2013
Insulin-like growth factor I (IGF-I) is implicated in breast cancer development and 1, 25-dihydroxyvitamin D3 (1, 25-D3) has been shown to attenuate prosurvival effects of IGF-I on breast cancer cells.
Brosseau, C, Colston, KW, Pirianov, G
core   +2 more sources

Overexpression of TMEM47 Induces Tamoxifen Resistance in Human Breast Cancer Cells

open access: yesTechnology in Cancer Research & Treatment, 2021
Background: Tamoxifen (TAM) is the eminent first-line drug for endocrine therapy of hormone receptor positive premenopausal breast cancer and reduces the risk of recurrence by ∼50%.
Xin Men   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy